Helsinn Hlthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HELSINN HLTHCARE, and when can generic versions of HELSINN HLTHCARE drugs launch?
HELSINN HLTHCARE has five approved drugs.
There are thirty-seven US patents protecting HELSINN HLTHCARE drugs.
There are three hundred and thirty-seven patent family members on HELSINN HLTHCARE drugs in fifty-eight countries and twenty-three supplementary protection certificates in fourteen countries.
Summary for Helsinn Hlthcare
International Patents: | 337 |
US Patents: | 37 |
Tradenames: | 3 |
Ingredients: | 4 |
NDAs: | 5 |
Drugs and US Patents for Helsinn Hlthcare
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | DISCN | Yes | No | 9,066,980*PED | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Helsinn Hlthcare | TRUSELTIQ | infigratinib phosphate | CAPSULE;ORAL | 214622-002 | May 28, 2021 | DISCN | Yes | No | 11,160,804 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Helsinn Hlthcare | TRUSELTIQ | infigratinib phosphate | CAPSULE;ORAL | 214622-001 | May 28, 2021 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Helsinn Hlthcare
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | 5,202,333*PED | ⤷ Try a Trial |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | CAPSULE;ORAL | 022233-001 | Aug 22, 2008 | 5,202,333 | ⤷ Try a Trial |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | 9,125,905 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Helsinn Hlthcare Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2004208505 | ⤷ Try a Trial |
Poland | 378398 | ⤷ Try a Trial |
China | 102655864 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Helsinn Hlthcare Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2785706 | PA2020510,C2785706 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: FOSNETUPITANTAS; REGISTRATION NO/DATE: EU/1/15/1001 20200316 |
2785706 | C20200029 00371 | Estonia | ⤷ Try a Trial | PRODUCT NAME: FOSNETUPITANT;REG NO/DATE: EU/1/15/1001; 18.03.2020 |
2785706 | 2020C/516 | Belgium | ⤷ Try a Trial | PRODUCT NAME: AKYNZEO - FOSNETUPITANT/PALONOSETRON; AUTHORISATION NUMBER AND DATE: EU/1/15/1001 20200318 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.